Science and Research

Immune Mechanisms in Pulmonary Fibrosis

Pulmonary fibrosis, particularly idiopathic pulmonary fibrosis, represents a chronic and progressive disease with high mortality and limited therapeutic options. Excessive deposition of extracellular matrix proteins results in fibrotic remodeling, alveolar destruction, and irreversible loss of lung function. Both innate and adaptive immune mechanisms contribute to fibrogenesis at several cellular and noncellular levels. Here, we summarize and discuss the role of immune cells (T cells, neutrophils, macrophages, and fibrocytes) and soluble mediators (cytokines and chemokines) involved in pulmonary fibrosis, pointing toward novel immune-based therapeutic strategies in the field.

  • Kolahian, S.
  • Fernandez, I. E.
  • Eickelberg, O.
  • Hartl, D.

Keywords

  • Animals
  • Cytokines/metabolism
  • Humans
  • Leukocytes/immunology
  • Models, Biological
  • Pulmonary Fibrosis/*immunology/therapy
  • *T cells
  • *fibrosis
  • *immunity
  • *lung
  • *neutrophils
Publication details
DOI: 10.1165/rcmb.2016-0121TR
Journal: Am J Respir Cell Mol Biol
Pages: 309-22 
Number: 3
Work Type: Review
Location: CPC-M
Disease Area: DPLD
Partner / Member: HMGU
Access-Number: 27149613
See publication on PubMed

DZL Engagements

chevron-down